{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:13:42Z","timestamp":1789902822654,"version":"4.0.1"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","award":["CMRPG3L1202"],"award-info":[{"award-number":["CMRPG3L1202"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["110-2314-B-182A-119-"],"award-info":[{"award-number":["110-2314-B-182A-119-"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>The VICTORIA trial demonstrated a significant decrease in cardiovascular events through vericiguat therapy. This study aimed to assess the potential mechanisms responsible for the reduction of cardiovascular events with vericiguat therapy in a rabbit model of myocardial infarction (MI).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>A chronic MI rabbit model was created through coronary artery ligation. Following 4 weeks, the hearts were harvested and Langendorff perfused. Subsequently, electrophysiological examinations and dual voltage-calcium optical mapping studies were conducted at baseline and after administration of vericiguat at a dose of 5 \u03bcmol\/L.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Acute vericiguat therapy demonstrated a significant reduction in premature ventricular beat burden and effectively suppressed ventricular arrhythmic inducibility. The electrophysiological influences of vericiguat therapy included an increased ventricular effective refractory period, prolonged action potential duration, and accelerated intracellular calcium (Ca<jats:sub>i<\/jats:sub>) homeostasis, leading to the suppression of action potential and Ca<jats:sub>i<\/jats:sub> alternans. The pacing-induced ventricular arrhythmias exhibited a reentrant pattern, attributed to fixed or functional conduction block in the peri-infarct zone. Vericiguat therapy effectively mitigated the formation of cardiac alternans as well as the development of reentrant impulses, providing additional anti-arrhythmic benefits.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>In the MI rabbit model, vericiguat therapy demonstrates anti-ventricular arrhythmia effects. The vericiguat therapy reduces ventricular ectopic beats, inhibiting the initiation of ventricular arrhythmias. Furthermore, the therapy successfully suppresses cardiac alternans, preventing conduction block and, consequently, the formation of reentry circuits.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0301970","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T17:57:36Z","timestamp":1713290256000},"page":"e0301970","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Vericiguat suppresses ventricular tachyarrhythmias inducibility in a rabbit myocardial infarction model"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6901-5951","authenticated-orcid":true,"given":"Po-Cheng","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ling","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4876-0714","authenticated-orcid":true,"given":"Hung-Ta","family":"Wo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0546-4181","authenticated-orcid":true,"given":"Hao-Tien","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Shien","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4465-0016","authenticated-orcid":true,"given":"Chung-Chuan","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,4,16]]},"reference":[{"issue":"12","key":"pone.0301970.ref001","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.mayocp.2014.08.022","article-title":"Sudden cardiac death from the perspective of coronary artery disease","volume":"89","author":"JD Sara","year":"2014","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"pone.0301970.ref002","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cardfail.2022.02.010","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure.","volume":"28","author":"M Writing Committee","year":"2022","journal-title":"Journal of cardiac failure"},{"issue":"36","key":"pone.0301970.ref003","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"TA McDonagh","year":"2021","journal-title":"European heart journal"},{"issue":"5","key":"pone.0301970.ref004","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1002\/ehf2.12924","article-title":"Sacubitril\/valsartan vs. angiotensin receptor inhibition in heart failure: a real\u2010world study in Taiwan.","volume":"7","author":"PC Chang","year":"2020","journal-title":"ESC heart failure"},{"issue":"20","key":"pone.0301970.ref005","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction","volume":"382","author":"PW Armstrong","year":"2020","journal-title":"The New England journal of medicine"},{"issue":"4","key":"pone.0301970.ref006","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00395-018-0679-9","article-title":"cGMP at the centre of attention: emerging strategies for activating the cardioprotective PKG pathway.","volume":"113","author":"M Park","year":"2018","journal-title":"Basic research in cardiology."},{"issue":"4","key":"pone.0301970.ref007","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jacc.2004.09.076","article-title":"Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial.","volume":"45","author":"J McMurray","year":"2005","journal-title":"Journal of the American College of Cardiology"},{"issue":"6","key":"pone.0301970.ref008","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.cardfail.2020.03.007","article-title":"Sacubitril\/Valsartan Therapy Ameliorates Ventricular Tachyarrhythmia Inducibility in a Rabbit Myocardial Infarction Model","volume":"26","author":"PC Chang","year":"2020","journal-title":"Journal of cardiac failure"},{"issue":"2","key":"pone.0301970.ref009","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/CIRCRESAHA.109.209841","article-title":"Mapping cardiac pacemaker circuits: methodological puzzles of the sinoatrial node optical mapping","volume":"106","author":"IR Efimov","year":"2010","journal-title":"Circulation research"},{"key":"pone.0301970.ref010","doi-asserted-by":"crossref","first-page":"105804","DOI":"10.1016\/j.biocel.2020.105804","article-title":"Cardiac optical mapping\u2014State-of-the-art and future challenges","volume":"126","author":"C O\u2019Shea","year":"2020","journal-title":"Int J Biochem Cell Biol"},{"issue":"12","key":"pone.0301970.ref011","doi-asserted-by":"crossref","first-page":"662","DOI":"10.21037\/atm-22-2583","article-title":"Soluble guanylate cyclase (sGC) stimulator vericiguat alleviates myocardial ischemia-reperfusion injury by improving microcirculation","volume":"10","author":"Y Cai","year":"2022","journal-title":"Ann Transl Med"},{"issue":"12","key":"pone.0301970.ref012","doi-asserted-by":"crossref","first-page":"5146","DOI":"10.1021\/acs.jmedchem.7b00449","article-title":"Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart Failure.","volume":"60","author":"M Follmann","year":"2017","journal-title":"J Med Chem"},{"issue":"20","key":"pone.0301970.ref013","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1161\/CIRCULATIONAHA.110.981738","article-title":"Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease","volume":"123","author":"JP Stasch","year":"2011","journal-title":"Circulation"},{"issue":"14","key":"pone.0301970.ref014","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1113\/JP271588","article-title":"Protection against ventricular fibrillation via cholinergic receptor stimulation and the generation of nitric oxide","volume":"594","author":"M Kalla","year":"2016","journal-title":"The Journal of physiology"},{"issue":"11","key":"pone.0301970.ref015","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1161\/hh2301.100801","article-title":"Nitric oxide modulates cardiac Na(+) channel via protein kinase A and protein kinase G.","volume":"89","author":"GU Ahmmed","year":"2001","journal-title":"Circulation research"},{"issue":"1","key":"pone.0301970.ref016","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.yjmcc.2010.02.015","article-title":"Modulation of cardiac ERG1 K(+) channels by cGMP signaling.","volume":"49","author":"M Mewe","year":"2010","journal-title":"Journal of molecular and cellular cardiology"},{"key":"pone.0301970.ref017","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.yjmcc.2013.03.013","article-title":"Caveolin-3 suppresses late sodium current by inhibiting nNOS-dependent S-nitrosylation of SCN5A","volume":"61","author":"J Cheng","year":"2013","journal-title":"Journal of molecular and cellular cardiology"},{"issue":"6","key":"pone.0301970.ref018","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1161\/CIRCEP.109.891440","article-title":"Alpha1-syntrophin mutations identified in sudden infant death syndrome cause an increase in late cardiac sodium current","volume":"2","author":"J Cheng","year":"2009","journal-title":"Circulation Arrhythmia and electrophysiology"},{"issue":"1","key":"pone.0301970.ref019","doi-asserted-by":"crossref","first-page":"11273","DOI":"10.1038\/s41598-021-90840-0","article-title":"Nitric oxide down-regulates voltage-gated Na(+) channel in cardiomyocytes possibly through S-nitrosylation-mediated signaling.","volume":"11","author":"P Wang","year":"2021","journal-title":"Sci Rep."},{"issue":"4","key":"pone.0301970.ref020","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1161\/01.RES.77.4.803","article-title":"cGMP-dependent protein kinase regulation of the L-type Ca2+ current in rat ventricular myocytes","volume":"77","author":"K Sumii","year":"1995","journal-title":"Circulation research"},{"issue":"2","key":"pone.0301970.ref021","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.yjmcc.2009.03.021","article-title":"Phosphodiesterase 5 restricts NOS3\/Soluble guanylate cyclase signaling to L-type Ca2+ current in cardiac myocytes","volume":"47","author":"H Wang","year":"2009","journal-title":"Journal of molecular and cellular cardiology"},{"issue":"33","key":"pone.0301970.ref022","doi-asserted-by":"crossref","first-page":"11720","DOI":"10.1074\/jbc.RA120.014054","article-title":"Muscarinic-dependent phosphorylation of the cardiac ryanodine receptor by protein kinase G is mediated by PI3K-AKT-nNOS signaling","volume":"295","author":"S Baine","year":"2020","journal-title":"The Journal of biological chemistry"},{"issue":"8","key":"pone.0301970.ref023","doi-asserted-by":"crossref","first-page":"H1189","DOI":"10.1152\/ajpheart.00392.2012","article-title":"SERCA Cys674 sulphonylation and inhibition of L-type Ca2+ influx contribute to cardiac dysfunction in endotoxemic mice, independent of cGMP synthesis","volume":"305","author":"IA Hobai","year":"2013","journal-title":"American journal of physiology Heart and circulatory physiology"},{"issue":"19","key":"pone.0301970.ref024","doi-asserted-by":"crossref","first-page":"12337","DOI":"10.1016\/S0021-9258(18)98901-5","article-title":"Cyclic GMP stimulates Na+\/Ca2+ exchange in vascular smooth muscle cells in primary culture","volume":"266","author":"K Furukawa","year":"1991","journal-title":"The Journal of biological chemistry"},{"issue":"3","key":"pone.0301970.ref025","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1124\/mol.110.069658","article-title":"Nitric oxide stimulates NCX1 and NCX2 but inhibits NCX3 isoform by three distinct molecular determinants","volume":"79","author":"A Secondo","year":"2011","journal-title":"Mol Pharmacol"},{"issue":"7","key":"pone.0301970.ref026","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/1440-1681.12231","article-title":"Cardiac alternans and intracellular calcium cycling.","volume":"41","author":"JN Edwards","year":"2014","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"12","key":"pone.0301970.ref027","doi-asserted-by":"crossref","first-page":"H2451","DOI":"10.1152\/ajpheart.00770.2011","article-title":"Mechanisms of ventricular arrhythmias: a dynamical systems-based perspective","volume":"302","author":"EM Cherry","year":"2012","journal-title":"American journal of physiology Heart and circulatory physiology"},{"issue":"4","key":"pone.0301970.ref028","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00228-020-03023-7","article-title":"Safety, pharmacodynamic, and pharmacokinetic characterization of vericiguat: results from six phase I studies in healthy subjects","volume":"77","author":"M Boettcher","year":"2021","journal-title":"Eur J Clin Pharmacol"},{"key":"pone.0301970.ref029","doi-asserted-by":"crossref","first-page":"6032631","DOI":"10.1155\/2019\/6032631","article-title":"LCZ696 Therapy Reduces Ventricular Tachyarrhythmia Inducibility in a Myocardial Infarction-Induced Heart Failure Rat Model.","volume":"2019","author":"PC Chang","year":"2019","journal-title":"Cardiovasc Ther"},{"issue":"2","key":"pone.0301970.ref030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/FJC.0000000000000598","article-title":"Paradoxical Effects of Sodium-Calcium Exchanger Inhibition on Torsade de Pointes and Early Afterdepolarization in a Heart Failure Rabbit Model","volume":"72","author":"PC Chang","year":"2018","journal-title":"Journal of cardiovascular pharmacology"},{"issue":"5","key":"pone.0301970.ref031","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1113\/expphysiol.2012.069369","article-title":"The mechanical uncoupler blebbistatin is associated with significant electrophysiological effects in the isolated rabbit heart","volume":"98","author":"KE Brack","year":"2013","journal-title":"Experimental physiology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0301970","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T17:58:02Z","timestamp":1713290282000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0301970"}},"subtitle":[],"editor":[{"given":"Elena G.","family":"Tolkacheva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,4,16]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0301970","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,16]]}}}